VALIDATE Annual Meeting 2021

 

Annual Meeting 2021

 

Since 2017, VALIDATE's Annual Meetings have provided members of our community with a chance to connect, network, build new collaborations and hear about some of the great research that our network has supported. Due to the COVID-19 pandemic, we were not able to meet in person so our 2021 Annual Meeting took place online, across three days: 15 September, 14 October, and 16 November 2021. We hope that by delivering an online meeting, even more members can take advantage of this opportunity to connect with fellow members and hear about the amazing work our community has undertaken over the past 4 years.

Agenda

Expand All

Day One of the VALIDATE Annual Meeting 2021 took place on 15 September 2021, over 60 VALIDATE members and was chaired by Prof Mitali Chatterjee.  Anyone you can watch the opening session above​, which includes talks from Helen McShane, Dr Himangi Bhardawaj MBE from British High Commission in India, and an update on VALIDATE from Samantha Vermaak.

VALIDATE members can watch the rest of the  Annual Meeting on the VALIDATE Hub.

 

Content

US
West

US East

Brazil

UK

South Africa

Tanzania

Iran

India

Thailand

Japan

Sydney

Welcome & Introduction

Professor Mitali Chatterjee chair & Prof Mitali Chatterjee, IPGMER - Chair

 

23:30 (Previous Day)

02:30

 

03:30

 

07:30

 

08:30

 

09:30

 

11:00

 

12:00

 

13:30

 

15:30

 

16:30

 

Talk From Prof Helen McShane

Prof Helen McShane, University of Oxford - VALIDATE Director

23:35 (Previous Day)

02:35

 

03:35

 

07:35

 

08:35

 

09:35

 

11:05

 

12:05

 

13:35

 

15:35

 

16:35

 

The Newton Fund India

Dr Himangi Bhardawaj MBE

23:45 (Previous Day)

02:45

 

03:45

 

07:45

 

08:45

 

09:45

 

11:15

 

12:15

 

13:45

 

15:45

 

16:45

 

VALIDATE Update

Mrs Samantha Vermaak, VALIDATE Network Manager

23:55 (Previous Day)

02:55

 

03:55

 

07:55

 

08:55

 

09:55

 

11:25

 

12:25

 

13:55

 

15:55

 

16:55

 

Characterising the cellular immunity and metabolic response to Mycobacterium tuberculosis and Burkholderia pseudomallei in Indian patients for vaccine design

Ms Aparna Dravid, Manipal Academy of Higher Education, India

00:15

 

03:15

 

04:15

 

08:15

 

09:15

 

10:15

 

11:45

 

12:45

 

14:15

 

16:15

 

17:15

 

Developing a mouse model of diabetes to evaluate vaccines for TB and melioidosis

Dr Elena Stylianou, University of Oxford, UK

00:30

 

03:30

 

04:30

 

08:30

 

09:30

 

10:30

 

12:00

 

13:00

 

14:30

 

16:30

 

17:30

 

Q&A

 

00:45

 

03:45

 

04:45

 

08:45

 

09:45

 

10:45

 

12:15

 

13:15

 

14:45

 

16:45

 

17:45

 

Break

01:00

 

04:00

 

05:00

 

09:00

 

10:00

 

11:00

 

12:30

 

13:30

 

15:00

 

17:00

 

18:00

 

Vaccines to target people with diabetes: characterising the pathways of immune response to M. tuberculosis and B. pseudomallei in people with diabetes compared to non-diabetics

Dr Patpong Rongkard, Mahidol Oxford Tropical Medicine Research Unit, Thailand

01:15

 

04:15

 

05:15

 

09:15

 

10:15

 

11:15

 

12:45

 

13:45

 

15:15

 

17:15

 

18:15

 

Characterising the BCG-induced antibody response to inform the design of improved vaccines against M.tuberculosis, M.leprae and M.bovis

Dr Rachel Tanner, University of Oxford, UK

01:30

 

04:30

 

05:30

 

09:30

 

10:30

 

11:30

 

13:00

 

14:00

 

15:30

 

17:30

 

18:30

 

Q&A

 

01:45

 

04:45

 

05:45

 

09:45

 

10:45

 

11:45

 

13:15

 

14:15

 

15:45

 

17:45

 

18:45

 

Break

02:00

 

05:00

 

06:00

 

10:00

 

11:00

 

12:00

 

13:30

 

14:30

 

16:00

 

18:00

 

19:00

 

ECR Open Forum

Mrs Samantha Vermaak, VALIDATE Network Manager

02:15

 

05:15

 

06:15

 

10:15

 

11:15

 

12:15

 

13:45

 

14:45

 

16:15

 

18:15

 

19:15

 

​ 

Samantha Sampson

The VALIDATE Annual Meeting Day Two took place on the 14 October 2022 and was chaired by VALIDATE Co Network Director Professor Samantha Sampson, from Stellenbosch University, South Africa

VALIDATE Members can watch the whole Annual Meeting on the VALIDATE Hub.

 

 

 

 

 

 

Content

US West 

US East 

Brazil 

UK 

S.Africa 

Tanzania 

Iran 

India 

Thailand 

Japan 

Sydney 

Introduction 

Prof Samantha Sampson, Stellenbosch University, South Africa

04:00 

07:00 

08:00 

12:00 

13:00 

14:00 

14:30 

16:30 

18:00 

20:00 

21:00 

UK Government Talk 

Mr Anthony Phillipson (UK High Commission in South Africa) 

04:05 

07:05 

08:05 

12:05 

13:05 

14:05 

14:35 

16:35 

18:05 

20:05 

21:05 

Vaccine Confidence Project 

Dr Emilie Karafillakis, LSHTM, UK

04:15 

07:15 

08:15 

12:15 

13:15 

14:15 

14:45 

16:45 

18:15 

20:15 

21:15 

T cell receptor sequencing to identify correlates of protection in human tuberculosis vaccine studies 

Dr Gabriele Pollara, UCL, UK 

04:30 

07:30 

08:30 

12:30 

13:30 

14:30 

15:00 

17:00 

18:30 

20:30 

21:30 

Modelling the impact of a transmission-blocking vaccine against leishmaniasis on sand fly vectorial capacity 

Dr Matthew Rogers, LSHTM, UK 

04:45 

07:45 

08:45 

12:45 

13:45 

14:45 

15:15 

17:15 

18:45 

20:45 

21:45 

Q&A 

05:00 

08:00 

09:00 

13:00 

14:00 

15:00 

15:30 

17:30 

19:00 

21:00 

22:00 

Break

05:15 

08:15 

09:15 

13:15 

14:15 

15:15 

15:45 

17:45 

19:15 

21:15 

22:15 

Innovative tools to measure mycobacterial antigen expression in tissue 

Dr Simon Waddell, University of Sussex, UK 

05:30 

08:30 

09:30 

13:30 

14:30 

15:30 

16:00 

18:00 

19:30 

21:30 

22:30 

An ex vivo model for understanding the impact of vaccination on Mycobacterial persister populations 

Prof Samantha Sampson, Stellenbosch University, South Africa 

05:45 

08:45 

09:45 

13:45 

14:45 

15:45 

16:15 

18:15 

19:45 

21:45 

22:45 

Q&A 

06:00 

09:00 

10:00 

14:00 

15:00 

16:00 

16:30 

18:30 

20:00 

22:00 

23:00 

Break

06:15 

09:15 

10:15 

14:15 

15:15 

16:15 

16:45 

18:45 

20:15 

22:15 

23:15 

Identification of Leishmania donovani and Mycobacterium tuberculosis- derived proteins on the surface of infected macrophages that are associated with ADCC induction 

Dr Mohamed Osman, University of York, UK 

06:30 

09:30 

10:30 

14:30 

15:30 

16:30 

17:00 

19:00 

20:30 

22:30 

23:30 

Natural variation of the bovine lymph node microenvironment and its possible effect on BCG immunogenicity 

Prof Bernardo Villarreal-Ramos, Aberystwyth University, UK 

06:45 

09:45 

10:45 

14:45 

15:45 

16:45 

17:15 

19:15 

20:45 

22:45 

23:45 

Q&A 

07:00 

10:00 

11:00 

15:00 

16:00 

17:00 

17:30 

19:30 

21:00 

23:00 

00:00 

Break

07:15 

10:15 

11:15 

15:15 

16:15 

17:15 

17:45 

19:45 

21:15 

23:15 

00:15 

ECR Open Forum

Mrs Samantha Vermaak, VALIDATE Network Manager

07:30 

10:30 

11:30 

15:30 

16:30 

17:30 

18:00 

20:00 

21:30 

23:30 

00:30 

 

 

 

 

 

maria adelaida gomez

Day Three of the Annual Meeting 2021 took place on 16 November 2021, VALIDATE and was chaired by VALIDATE Network Investigator Dr Maria Adelaida Gomez, CIDEIM, Colombia

VALIDATE Members can watch the whole Annual Meeting on the VALIDATE Hub.

 

 

 

 

Content

US West

US East 

 Brazil

GMT

S.Africa

Tanzania

Iran

India

Thailand

Japan

Sydney

Welcome & Introduction

Dr Maria Adelaida Gomez & Ambassador

07:00

10:00

12:00

15:00

17:00

18:00

18:30

19:30

22:00

00:00

02:00

Talk from Ambassador

Mr Colin Martin-Reynolds CMG, British Ambassador to Colombia

07:05

10:05

12:05

15:05

17:05

18:05

18:35

19:35

22:05

00:05

02:05

Cytomegalovirus as a risk factor for TB and leishmaniasis

Dr Lisa Stockdale, University of Oxford, UK

07:15

10:15

12:15

15:15

17:15

18:15

18:45

19:45

22:15

00:15

02:15

Elucidating the T-cell epitopes and T-cells responses of two
B.pseudomallei vaccine antigens

Dr Julen Tomás Cortázar, University College Dublin, Ireland

07:30

10:30

12:30

15:30

17:30

18:30

19:00

20:00

22:30

00:30

02:30

Investigating the BCG-induced Natural Killer (NK) cell response i
n cattle and humans

Dr Iman Satti, University of Oxford, UK

07:45

10:45

12:45

15:45

17:45

18:45

19:15

20:15

22:45

00:45

02:45

Q&A

08:00

11:00

13:00

16:00

18:00

19:00

19:30

20:30

23:00

01:00

03:00

Break

08:10

11:10

13:10

16:10

18:10

19:10

19:40

20:40

23:10

01:10

03:10

Metabolic reprogramming of skin microenvironment for improved
BCG vaccine efficacy

Titular Prof Francisco Javier Sánchez-García,
Instituto Politécnico Nacional, Mexico

08:20

11:20

13:20

16:20

18:20

19:20

19:50

20:50

23:20

01:20

03:20

Development of an RNA based vaccine Mycobacterium tuberculosis

Affiliate Prof Rhea Coler, Seattle Children's Research Institute, USA

08:35

11:35

13:35

16:35

18:35

19:35

20:05

21:05

23:35

01:35

03:35

The effect of BCG vaccination in immune responses against visceral
leishmaniasis in a natural (canine) model of infection 

Dr Isadora Lima, Oswaldo Cruz Foundation, FIOCRUZ, UK

08:50

11:50

13:50

16:50

18:50

19:50

20:20

21:20

23:50

01:50

03:50

Q&A

09:05

12:05

14:05

17:05

19:05

20:05

20:35

21:35

00:05

02:05

04:05

Break

09:15

12:15

14:15

17:15

19:15

20:15

20:45

21:45

00:15

02:15

04:15

How do functional and metabolic characteristics of trained monocytes
affect their anti-bacterial activity?

Dr Steven Smith, Brunel University, UK

09:25

12:25

14:25

17:25

19:25

20:25

20:55

21:55

00:25

02:25

04:25

Overcoming innate immune tolerance in the respiratory tract for
optimal vaccine design

Dr Rajko Reljic, SGUL, UK

09:40

12:40

14:40

17:40

19:40

20:40

21:10

22:10

00:40

02:40

04:40

Establishment of a functional assay panel to evaluate the role of
antibodies in defence against melioidosis and tuberculosis

Dr Panjaporn Chaichana, Mahidol Oxford Tropical Medicine
Research Unit (MORU), Thailand

09:55

12:55

14:55

17:55

19:55

20:55

21:25

22:25

00:55

02:55

04:55

Q&A

10:10

13:10

15:10

18:10

20:10

21:10

21:40

22:40

01:10

03:10

05:10

Break

10:20

13:20

15:20

18:20

20:20

21:20

21:50

22:50

01:20

03:20

05:20

ECR Open Forum

Mrs Samantha Vermaak, VALIDATE Network Manager

10:30

13:30

15:30

18:30

20:30

21:30

22:00

23:00

01:30

03:30

05:30